by Jordana Choucair | Oct 3, 2022 | Life Sciences
The U.S. the Department of Health and Human Services (HHS) released a new report indicating that more than 1,200 prescription drugs rose in price faster than the rate of inflation between July 2021 and July 2022. The report specifically found that during that time...
by Jordana Choucair | Sep 30, 2022 | Life Sciences
The FDA approved Amylyx Pharmaceuticals Inc.’s ALS drug Relyvrio, the first treatment for Lou Gehrig’s disease that the agency has cleared in five years. Patient advocacy groups had pressured the FDA to approve the new treatment, though there’s still some...
by Jordana Choucair | Sep 29, 2022 | Life Sciences
The Food and Drug Administration (FDA) issued a proposed rule that would change the nutrition standards that foods must meet before they can carry the “healthy” label on their packages. The agency said the change “would align the definition of the...
by Jordana Choucair | Sep 28, 2022 | Life Sciences
The U.S. Food and Drug Administration (FDA) said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 tests. Companies that request EUAs for their tests will have to demonstrate the tests are likely to have a significant...
by Jordana Choucair | Sep 27, 2022 | Life Sciences
Pfizer announced it asked the Food and Drug Administration (FDA) to approve its omicron-specific COVID-19 booster shot for children between the ages of 5 and 11. Pfizer asked the FDA to authorize a 10-microgram dose for children, one-third of the 30 microgram dose...
by Jordana Choucair | Sep 26, 2022 | Life Sciences
Moderna announced that it asked the Food and Drug Administration (FDA) to authorize its omicron booster shots for children. Moderna filed two separate FDA authorization requests, one for adolescents ages 12 to 17 and another for kids ages 6 to 11. The biotech company...
Recent Comments